“TECNALIA committed to the sector’s most important pharmaceutical event: CPhI 2021”
The Pharma Lab_Services business area at TECNALIA has presented its analytical and galenic pharmaceutical development requirements services, stability studies (ICH) or CDMO to attendees.
With physical presence on a stand and a team made up of our colleagues, Eider Larrarte, Itziar Echevarria, Maite Zubizarreta, Silvia Alonso and Francisco Ledo, TECNALIA reaffirms its commitment and presence at CPhI 2021, theleading annual event for the pharmaceutical industry and technological services related pharmaceutical drugs.
On this occasion, marked by the COVID-19 situation, most of the attendees were European, the main growth target market for Pharma_Lab Services, compared to previous fairs in which Asia and America was prominent.
Analytical and galenic pharmaceutical development, CDMO or ICH; some of the services presented at CPhI 2021
Over the fair’s three years, we have been able to establish direct contact with more than 45 companies from the pharmaceutical sector ,through B2B meetings arranged before the fair and on site contacts, mainly from the United Kingdom, France, Germany, Netherlands or Poland. Of course, that is not to forget our contacts with Spanish companies with which we usually work.
Our services focus has centred on analytical pharmaceutical development, as well as galenic development orpharmaceutical contract manufacturing (CDMO). We can highlight that since the fair to the present day, a dozen confidentiality agreements have got off the ground, which will serve as a starting point to establish future collaborations.
See you at CPhl 2022
The results obtained at the fair and the great acceptance by clients and potential clients has encouraged us to continue our objective of internationalising the Pharma_Lab services, focusing specifically on Europe and being able to return to this fair in 2022. It will be our main tool to achieve a greater presence of our services, new clients and territories.